Acelity has announced that its Tielle foam dressing family is now available in the United States. The Tielle dressing family expands the advanced wound therapeutics portfolio from Acelity. This expansion complements a broad range of existing solutions for chronic and acute wounds and provides clinicians with efficient and cost-effective options for treating patients.

The company announced the availability of these products at the joint meeting of the Symposium of Advanced Wound Care and the Wound Healing Society (SAWC Spring/WHS) in Atlanta.

“Our goal was to reinvigorate the range of proven Tielle dressings and introduce it to clinicians here in the U.S. who are seeking effective solutions for all patients, including the most compromised,” said Joe Woody, president and chief executive officer of Acelity. “We aim to strengthen our partnership with nurses and physicians by broadening our platform to include an extensive range of dressings, advancements in negative pressure technology and new innovations designed to help speed healing for patients and reduce the overall cost of care.”

The Tielle foam dressing family was designed to meet the needs of health care professionals, including exudate management and reduced pain for the patient at dressing removal.